InsiderTrades

Form 4 for DNA Ginkgo Bioworks Holdings, Inc.

Accepted 2026-03-18 00:00:00 ET · period of report 2026-03-13 · accession 0001628280-26-019475 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2026-03-18 2026-03-16 DNA Coen Steven P. See remarks S - Sale+OE $6.74 -708 9,099 -7% -$4,772
DM 2026-03-18 2026-03-13 DNA Coen Steven P. See remarks M - OptEx — +1,486 9,807 +18% —
DM 2026-03-18 2026-03-13 DNA Coen Steven P. See remarks M - OptEx — -1,486 8,231 -15% —

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2026-03-16 S D 708 $6.74 9,099 D — —
2 Common Class A Common Stock 2026-03-13 M A 1,174 — 9,495 D — — (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.
3 Common Class A Common Stock 2026-03-13 M A 312 — 9,807 D — — (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.
4 Derivative Restricted Stock Units 2026-03-13 M D 312 — 3,755 D — · — to — 312 Class A Common Stock (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. (F4) The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter.
5 Derivative Restricted Stock Units 2026-03-13 M D 1,174 — 8,231 D — · — to — 1,174 Class A Common Stock (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. (F3) The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter.